Search Results - "Lyons, Yasmin A"

Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer by Frumovitz, Michael, Burzawa, Jennifer K, Byers, Lauren A, Lyons, Yasmin A, Ramalingam, Preetha, Coleman, Robert C, Brown, Jubilee

“…Abstract Objectives Small cell cervical cancer is a rare malignancy with limited treatment options for recurrent disease. We sought to determine if tumor…”
Get full text

Combined VEGFR and MAPK pathway inhibition in angiosarcoma by Wagner, Michael J., Lyons, Yasmin A., Siedel, Jean H., Dood, Robert, Nagaraja, Archana S., Haemmerle, Monika, Mangala, Lingegowda S., Chanana, Pritha, Lazar, Alexander J., Wang, Wei-Lien, Ravi, Vinod, Holland, Eric C., Sood, Anil K.

“…Angiosarcoma is an aggressive malignancy of endothelial cells that carries a high mortality rate. Cytotoxic chemotherapy can elicit clinical responses, but the…”
Get full text

Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy by Lyons, Yasmin A, Pradeep, Sunila, Wu, Sherry Y, Haemmerle, Monika, Hansen, Jean M, Wagner, Michael J, Villar-Prados, Alejandro, Nagaraja, Archana S, Dood, Robert L, Previs, Rebecca A, Hu, Wei, Zhao, Yang, Mak, Duncan H, Xiao, Zhilan, Melendez, Brenda D, Lizee, Gregory A, Mercado-Uribe, Imelda, Baggerly, Keith A, Hwu, Patrick, Liu, Jinsong, Overwijk, Willem W, Coleman, Robert L, Sood, Anil K

“…Anti-angiogenesis therapy has shown clinical benefit in patients with high-grade serous ovarian cancer (HGSC), but adaptive resistance rapidly emerges. Thus,…”
Get full text

Immune cell profiling in cancer: molecular approaches to cell-specific identification by Lyons, Yasmin A., Wu, Sherry Y., Overwijk, Willem W., Baggerly, Keith A., Sood, Anil K.

“…The immune system has many important regulatory roles in cancer development and progression. Given the emergence of effective immune therapies against many…”
Get full text

Multimodal perioperative pain protocol for gynecologic laparotomy is associated with reduced hospital length of stay by Mattson, Jordan, Thayer, MacKenzie, Mott, Sarah L., Lyons, Yasmin A., Hardy‐Fairbanks, Abbey, Hill, Emily K.

“…Objectives The primary objective was to evaluate the impact of a multimodal perioperative pain regimen on length of hospital stay for patients undergoing…”
Get full text

Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers by Hatakeyama, Hiroto, Wu, Sherry Y., Lyons, Yasmin A., Pradeep, Sunila, Wang, Wanqin, Huang, Qian, Court, Karem A., Liu, Tao, Nie, Song, Rodriguez-Aguayo, Cristian, Shen, Fangrong, Huang, Yan, Hisamatsu, Takeshi, Mitamura, Takashi, Jennings, Nicholas, Shim, Jeajun, Dorniak, Piotr L., Mangala, Lingegowda S., Petrillo, Marco, Petyuk, Vladislav A., Schepmoes, Athena A., Shukla, Anil K., Torres-Lugo, Madeline, Lee, Ju-Seog, Rodland, Karin D., Fagotti, Anna, Lopez-Berestein, Gabriel, Li, Chun, Sood, Anil K.

“…Even though hyperthermia is a promising treatment for cancer, the relationship between specific temperatures and clinical benefits and predictors of…”
Get full text

Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation by Lyons, Yasmin A, Frumovitz, Michael, Soliman, Pamela T

“…Highlights • Molecular testing may play a role in the determination of targeted therapy treatment options. • Targeted therapy provides treatment options for…”
Get full text

Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome by Haldar, Rita, Shaashua, Lee, Lavon, Hagar, Lyons, Yasmin A., Zmora, Oded, Sharon, Eran, Birnbaum, Yehudit, Allweis, Tanir, Sood, Anil K., Barshack, Iris, Cole, Steve, Ben-Eliyahu, Shamgar

“…•Even before surgery, we observed pro-inflammatory/pro-metastatic responses in breast cancer patients.•Propranolol (β-blocker) and etodolac (COX2 inhibitor)…”
Get full text

Gynecologic Oncology: Challenges of Minimally Invasive Surgery In a Field of Maximal Complexities by LYONS, YASMIN A., STEPHAN, JEAN-MARIE, GONZALEZ BOSQUET, JESUS, GOODHEART, MICHAEL J.

“…Minimally invasive surgery has become a standard in the surgical treatment for many women with gynecologic cancers. Within the scope of minimally invasive…”
Get full text

Abstract 723: Distinguishing macrophages by a unique gene signature to measure response to treatment by Lyons, Yasmin A., Pradeep, Sunila, Hansen, Jean M., Previs, Rebecca A., Yao, Hui, Baggerly, Keith A., Sood, Anil K.

“…Abstract Objectives: Tumor-associated macrophage infiltration is associated with poor prognosis, making macrophage depletion an ideal therapy. This study aims…”
Get full text

Corrigendum to “Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer” [Gynecol. Oncol. 141 (2016) 588–591] by Frumovitz, Michael, Burzawa, Jennifer K, Byers, Lauren A, Lyons, Yasmin A, Ramalingam, Preetha, Coleman, Robert L, Brown, Jubilee

Get full text

A rectovaginal septum mass in a BRCA1 positive patient years after risk reducing surgery: A case report by Blankenship, Logan, Lyons, Yasmin A., Dao Campi, Haisar, Valente, Philip T., Barnes, Laura, Kost, Edward R.

“…•Rectovaginal septum mass in BRCA1 positive patient after risk reducing BSO years prior.•Papillary serous carcinoma presenting as a rectovaginal septum…”
Get full text

Non‐16/18 high‐risk HPV infection predicts disease persistence and progression in women with an initial interpretation of LSIL by Lyons, Yasmin A., Kamat, Aparna A., Zhou, Haijun, Mody, Dina R., Schwartz, Mary R., Hobday, Christopher, Ge, Yimin

“…BACKGROUND The current management strategy for women with low‐grade squamous intraepithelial lesions (LSILs) is inefficient and expensive because of the…”
Get full text

Certain fusion genes are associated with clinical outcomes in high grade serous ovarian cancer by Newtson, Andreea Mihai, Reyes, Henry D., Lyons, Yasmin A., Devor, Eric, Goodheart, Michael Joseph, Gonzalez-Bosquet, Jesus

Get full text

Identification of novel long non-coding RNAs in ovarian cancer and their impact on overall survival by Newtson, Andreea Mihai, Cardillo, Nicholas David, Russo, Douglas, Reyes, Henry D., Lyons, Yasmin A., Devor, Eric, Goodheart, Michael Joseph, Gonzalez-Bosquet, Jesus

Get full text

Interval debulking surgery is not worth the wait: A National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy by Lyons, Yasmin A., Reyes, Henry E., McDonald, Megan E., Newtson, Andreea, Devor, Eric, Bender, David P., Goodheart, Michael J., Gonzalez Bosquet, Jesus

Get full text

Multimodal perioperative pain protocol for Gynecologic Oncology laparotomy reduces length of hospital stay by Mattson, Jordan N., Thayer, MacKenzie, Mott, Sarah L., Lyons, Yasmin A., Reyes, Henry D., McDonald, Megan E., Hardy-Fairbanks, Abbey J., Hill, Emily K.

Get full text

Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP) by Mitamura, T, Pradeep, S, McGuire, M, Wu, S Y, Ma, S, Hatakeyama, H, Lyons, Y A, Hisamatsu, T, Noh, K, Villar-Prados, A, Chen, X, Ivan, C, Rodriguez-Aguayo, C, Hu, W, Lopez-Berestein, G, Coleman, R L, Sood, A K

“…Anti-vascular endothelial growth factor (VEGF) therapy has demonstrated efficacy in treating human metastatic cancers, but therapeutic resistance is a…”
Get full text

Abstract A026: Identifying mechanisms to target in combination with trametinib to improve therapeutic efficacy in low-grade serous ovarian cancer by Peplinski, Rebekah M., Nobre, Silvana Pedra, Schillo, Jacob L., Ulmer, Keely K., Lyons, Yasmin A., Riordan, Jesse D., Goodheart, Michael J., Dupuy, Adam J.

“…Abstract Low-grade serous ovarian cancer (LGSOC) has recently been characterized as a unique subtype of ovarian cancer with distinct molecular characteristics,…”
Get full text

Abstract 788: Less is more: macrophage depletion via CSF1/CSF1R pathway improves anti-VEGF therapy after adaptive resistance by Lyons, Yasmin A., Pradeep, Sunila, Hansen, Jean M., Wagner, Michael J., Dood, Robert L., Wu, Sherry Y., Previs, Rebecca A., Hu, Wei, Coleman, Robert L., Sood, Anil K.

“…Abstract Objectives: Anti-angiogenesis therapy shows clinical benefit in patients with high-grade serous ovarian cancer (HGSC), but adaptive resistance…”
Get full text